Mylan Tech Viatris Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MYLAN TECH VIATRIS, and what generic and branded alternatives to MYLAN TECH VIATRIS drugs are available?
MYLAN TECH VIATRIS has two approved drugs.
Drugs and US Patents for Mylan Tech Viatris
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan Tech Viatris | BUPRENORPHINE | buprenorphine | FILM, EXTENDED RELEASE;TRANSDERMAL | 210162-004 | May 3, 2021 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Mylan Tech Viatris | METHYLPHENIDATE | methylphenidate | FILM, EXTENDED RELEASE;TRANSDERMAL | 206497-004 | Mar 14, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Mylan Tech Viatris | METHYLPHENIDATE | methylphenidate | FILM, EXTENDED RELEASE;TRANSDERMAL | 206497-001 | Mar 14, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Mylan Tech Viatris | BUPRENORPHINE | buprenorphine | FILM, EXTENDED RELEASE;TRANSDERMAL | 210162-002 | May 3, 2021 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Mylan Tech Viatris | BUPRENORPHINE | buprenorphine | FILM, EXTENDED RELEASE;TRANSDERMAL | 210162-003 | May 3, 2021 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Mylan Tech Viatris | BUPRENORPHINE | buprenorphine | FILM, EXTENDED RELEASE;TRANSDERMAL | 210162-001 | May 3, 2021 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Mylan Tech Viatris | METHYLPHENIDATE | methylphenidate | FILM, EXTENDED RELEASE;TRANSDERMAL | 206497-002 | Mar 14, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.